NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
VRA
Vera Bradley, Inc.
There isn't enough reported data to score VRA yet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
VRA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
VRA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
VRA PE Valuation
VRA has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
VRA Forward outlook
There aren't enough analyst estimates for VRA to show an outlook.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over VRA on earnings quality, reporting a profit while its opponent remains loss making.
VRA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.37 | +$3.08 |
| Q2 2026 | -$0.69 | +$2.40 |
| Q1 2026 | -$1.72 | +$0.43 |
| Q4 2025 | -$3.43 | -$2.84 |
| Q3 2025 | -$3.45 | -11600% |
| Q2 2025 | -$3.09 | -2307% |
| Q1 2025 | -$2.15 | -960% |
| Q4 2024 | -$0.59 | +$0.01 |
VRA is still losing money, but far less than before: $0.37 per share over the past year, against $3.45 at its worst in mid-2025.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over VRA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over VRA on profitability, with a higher operating margin.
VRA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $71.6M | +1.1% |
| Q2 2026 | $55.7M | +7.8% |
| Q1 2026 | $84.9M | -15% |
| Q4 2025 | $62.3M | -23% |
| Q3 2025 | $70.9M | -36% |
| Q2 2025 | $51.7M | -36% |
| Q1 2025 | $100M | -25% |
| Q4 2024 | $80.6M | -30% |
VRA's revenue has slid since its 2020 peak: $72M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +12 points |
| Q2 2026 | -8.3% | +26 points |
| Q1 2026 | 3.2% | +27 points |
| Q4 2025 | -20% | -6.6 points |
| Q3 2025 | -6.5% | -9.1 points |
| Q2 2025 | -35% | -20 points |
| Q1 2025 | -23% | -21 points |
| Q4 2024 | -13% | -19 points |
VRA's operating margin was 5.8% last quarter, up 12 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
VRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.3M | +$28.4M |
| Q2 2026 | -$5.6M | +$14.2M |
| Q1 2026 | $17.1M | -1.3% |
| Q4 2025 | -$4.5M | +$20.6M |
| Q3 2025 | -$6.1M | -$4.8M |
| Q2 2025 | -$19.8M | -$4.4M |
| Q1 2025 | $17.3M | -33% |
| Q4 2024 | -$25M | -686% |
VRA has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over VRA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
VRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.7% | +1.9M shares |
| 1 year | +7.4% | +2.1M shares |
| 3 years | -3.6% | -1.1M shares |
| 5 years | -13% | -4.5M shares |
| Available history | -12% | -4.1M shares |
VRA has 30M diluted shares, up 7.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $585,000 |
| Q4 2024 | $5.3M |
| Q3 2024 | $9.5M |
| Q2 2024 | $6.3M |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
VRA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -14.1x | Net Cash |
| Q2 2024 | -4.2x | Net Cash |
| Q1 2024 | -4.2x | Net Cash |
| Q2 2022 | -2.1x | Net Cash |
| Q1 2022 | -2.4x | Net Cash |
| Q4 2021 | -2.0x | Net Cash |
| Q3 2021 | -1.8x | Net Cash |
| Q2 2021 | -1.1x | Net Cash |
VRA has more cash than debt.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
VRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 82.4 | Overbought |
| Stochastic | 89.3 | Overbought |
VRA's weekly RSI is 82 (overbought) and its Stochastic is 89 (overbought).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
VRA PE vs Consumer Cyclical Sector
| Metric | VRA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
VRA has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
VRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.91 | 28% above |
| 20 week MA | $4.50 | 68% above |
| 50 week MA | $3.67 | 106% above |
| 100 week MA | $3.08 | 145% above |
| 200 week MA | $4.72 | 60% above |
VRA has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
VRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.6 | $8.10 | -30% |
| 2021 | $8.10 | $8.54 | +5.4% |
| 2022 | $8.54 | $4.13 | -52% |
| 2023 | $4.13 | $7.70 | +86% |
| 2024 | $7.70 | $3.60 | -53% |
| 2025 | $3.60 | $2.28 | -37% |
| 2026 YTD | $2.28 | $7.56 | +232% |
VRA has the edge over NKE on returns for 2026, with the stronger performance.